↓ Skip to main content

MONARCH 3 final PFS: a randomized study of abemaciclib as initial therapy for advanced breast cancer

Overview of attention for article published in npj Breast Cancer, January 2019
Altmetric Badge

About this Attention Score

  • In the top 5% of all research outputs scored by Altmetric
  • Among the highest-scoring outputs from this source (#29 of 324)
  • High Attention Score compared to outputs of the same age (94th percentile)

Mentioned by

news
4 news outlets
policy
1 policy source
twitter
8 tweeters

Citations

dimensions_citation
139 Dimensions

Readers on

mendeley
193 Mendeley
Title
MONARCH 3 final PFS: a randomized study of abemaciclib as initial therapy for advanced breast cancer
Published in
npj Breast Cancer, January 2019
DOI 10.1038/s41523-018-0097-z
Pubmed ID
Authors

Stephen Johnston, Miguel Martin, Angelo Di Leo, Seock-Ah Im, Ahmad Awada, Tammy Forrester, Martin Frenzel, Molly C. Hardebeck, Joanne Cox, Susana Barriga, Masakazu Toi, Hiroji Iwata, Matthew P. Goetz

Twitter Demographics

The data shown below were collected from the profiles of 8 tweeters who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 193 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 193 100%

Demographic breakdown

Readers by professional status Count As %
Researcher 33 17%
Other 25 13%
Student > Bachelor 21 11%
Student > Ph. D. Student 17 9%
Student > Master 16 8%
Other 33 17%
Unknown 48 25%
Readers by discipline Count As %
Medicine and Dentistry 79 41%
Pharmacology, Toxicology and Pharmaceutical Science 14 7%
Biochemistry, Genetics and Molecular Biology 13 7%
Agricultural and Biological Sciences 7 4%
Psychology 3 2%
Other 18 9%
Unknown 59 31%

Attention Score in Context

This research output has an Altmetric Attention Score of 38. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 25 March 2021.
All research outputs
#711,468
of 18,451,607 outputs
Outputs from npj Breast Cancer
#29
of 324 outputs
Outputs of similar age
#20,251
of 347,783 outputs
Outputs of similar age from npj Breast Cancer
#1
of 1 outputs
Altmetric has tracked 18,451,607 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 96th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 324 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 17.3. This one has done particularly well, scoring higher than 91% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 347,783 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 94% of its contemporaries.
We're also able to compare this research output to 1 others from the same source and published within six weeks on either side of this one. This one has scored higher than all of them